RECURSION PHARMACEUTICALS, INC. (RXRX) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US75629V1044
RECURSION PHARMACEUTICALS, INC. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 74.68 m USD |
| Gross profit | 3.73 m USD |
| Operating income | -648.13 m USD |
| EBIT | -643.09 m USD |
| Net income | -644.76 m USD |
| Diluted EPS – continuing operations | -1.44 USD |
Full history since 2018, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About RECURSION PHARMACEUTICALS, INC.
Recursion Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United States and the United Kingdom. The company develops REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-617, which is in Phase 1/2 clinical trial to treat advanced solid tumors; REC-1245, which is in Phase 1/2 clinical trial to treat biomarker-enriched solid tumors and lymphoma; REC-3565 that is in Phase 1/2 for the treatment of relapsed or refractory B-cell malignancies; and REC-4539, a reversible, CNS penetrant, orally bioavailable, and potential best-in-class inhibitor of LSD1 for the treatment of solid tumors and hematology oncology. Its preclinical stage product includes REC-7735 for the treatment of HR+ breast cancer; and REC-102 for the treatment of hypophosphatasia. The company has collaboration and agreement with Roche & Genentech; Sanofi; Bayer AG; Tempus; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.
More stocks
- Hesai Group Sponsored ADR (HSAI)
- WAFD INC (WAFD)
- Cosmax Inc (192820.KS)
- Worthington Steel, Inc. (WS)
- Guangzhou Kingmed Diagnostics Group Co Ltd (603882.SS)
- Cadeler A/S (CADLR.OL)
- Baldwin Insurance Group, Inc. (BWIN)
- Proto Labs Inc (PRLB)
- Hefei Meiya Optoelectronic Technology Inc (002690.SZ)
- Philip Morris CR A.S. (TABAK.PR)
- Scandic Hotels Group AB (SHOT.ST)
- Stagwell Inc (STGW)
Not investment advice. All data without warranty, price as of 28.10.2026. Details in the risk notice.